GITNUXREPORT 2026

Orthopedic Device Industry Statistics

The global orthopedic device market is large and growing steadily across many segments and regions.

Sarah Mitchell

Sarah Mitchell

Senior Researcher specializing in consumer behavior and market trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

Stryker Corporation held 14.2% global market share in orthopedic devices in 2023, with revenues of USD 8.1 billion.

Statistic 2

Zimmer Biomet captured 12.5% share, generating USD 7.4 billion from orthopedics in 2023.

Statistic 3

DePuy Synthes (J&J) led with 15.8% share in hips and knees, USD 9.0 billion sales.

Statistic 4

Smith & Nephew had 9.3% market share, USD 5.3 billion orthopedic revenue in 2023.

Statistic 5

Medtronic dominated spine with 18% share, USD 2.4 billion in 2023.

Statistic 6

Globus Medical held 7.2% in spine devices, revenues USD 1.2 billion in 2023.

Statistic 7

Wright Medical (Stryker) had 6.8% in extremities post-acquisition in 2023.

Statistic 8

Conformis specialized in patient-specific knees, 1.5% niche share in 2023.

Statistic 9

NuVasive (Globus) 5.4% spine share, USD 1.1 billion before merger in 2023.

Statistic 10

Paragon 28 led foot/ankle with 4.1% share, USD 0.6 billion in 2023.

Statistic 11

Integra LifeSciences held 3.7% in orthobiologics, USD 1.0 billion revenue.

Statistic 12

Arthrex dominated arthroscopy at 22%, USD 3.2 billion in sports medicine 2023.

Statistic 13

CONMED 4.5% in arthroscopy tools, USD 0.7 billion in 2023.

Statistic 14

Becton Dickinson (BD) 5.2% in trauma fixation post-acquisition.

Statistic 15

Exactech had 2.8% in joints before bankruptcy filing in 2023.

Statistic 16

SeaSpine (N脊椎) 2.1% share in biologics and spine in 2023.

Statistic 17

Orthofix Medical 3.0% in spine and trauma, USD 0.5 billion.

Statistic 18

Coloplast entered with 1.2% via acquisitions in pelvic orthopedics 2023.

Statistic 19

BioVentrix niche in cardiac ortho crossover, 0.5% emerging share.

Statistic 20

TeDan Surgical Innovations 0.8% in power tools.

Statistic 21

In2Bones Global 1.1% in upper extremities trauma.

Statistic 22

Core Medical 0.9% in braces and supports.

Statistic 23

DJO Global (Colfax) 4.2% in rehab devices pre-sale.

Statistic 24

Enovis post-merger held 6.5% in extremities and rehab 2023.

Statistic 25

Hologic 2.3% via interstitial brachytherapy ortho apps.

Statistic 26

Implanet niche dynamic stabilization 0.4% spine share.

Statistic 27

Joimax 1.8% in endoscopic spine.

Statistic 28

K2M (Globus) integrated 3.5% complex spine share.

Statistic 29

Lanx (ZT) legacy 1.0% in fusion tech.

Statistic 30

Misonix (Stryker) ultrasonic ortho tools 0.7% share.

Statistic 31

Hospitals accounted for 62% of orthopedic device end-use market share in 2023, purchasing USD 35.5 billion worth.

Statistic 32

Orthopedic clinics and ambulatory surgical centers held 28% share, valued at USD 16.0 billion in 2023.

Statistic 33

Trauma centers represented 10% of end-users, with USD 5.7 billion in devices in 2023.

Statistic 34

U.S. hospitals performed 70% of joint replacements, using 55% of implants in 2023.

Statistic 35

European ambulatory centers grew 7.2% in orthopedic procedures, handling 22% market in 2023.

Statistic 36

Asia-Pacific specialty clinics adopted 35% more orthobiologics in 2023.

Statistic 37

Home healthcare for braces and supports reached 12% end-use share in 2023, USD 6.7 billion.

Statistic 38

Rehabilitation centers used 18% of extremity devices in 2023 globally.

Statistic 39

Sports injury clinics accounted for 15% of arthroscopy device purchases in 2023.

Statistic 40

Academic medical centers conducted 25% of spine surgeries in U.S. in 2023.

Statistic 41

Private orthopedic practices in India handled 40% of trauma cases in 2023.

Statistic 42

Veterans hospitals in U.S. procured USD 1.2 billion in orthopedics in 2023.

Statistic 43

Pediatric hospitals used 8% of pediatric-specific orthopedic devices in 2023.

Statistic 44

Dialysis centers integrated orthopedics for 5% of bone health devices in 2023.

Statistic 45

Outpatient facilities in Europe rose to 32% of knee replacements in 2023.

Statistic 46

Military medical facilities purchased USD 0.8 billion in trauma devices in 2023.

Statistic 47

Physiotherapy centers adopted 20% of supportive braces market in 2023.

Statistic 48

Emergency departments handled 45% of initial trauma device applications in 2023.

Statistic 49

Cosmetic surgery clinics used 7% of facial orthopedics in 2023.

Statistic 50

Geriatric care homes increased orthopedic aid usage by 15% in 2023.

Statistic 51

Dental clinics for TMJ orthopedics accounted for 3% niche in 2023.

Statistic 52

Occupational health centers procured 10% of work-related injury devices in 2023.

Statistic 53

Bariatric surgery follow-ups used 6% of joint support devices post-weight loss in 2023.

Statistic 54

Oncology centers integrated 4% orthopedic prosthetics for bone cancer in 2023.

Statistic 55

The global orthopedic devices market was valued at USD 57.2 billion in 2023 and is expected to grow at a CAGR of 4.6% from 2024 to 2030, reaching USD 78.6 billion by 2030.

Statistic 56

In 2022, the U.S. orthopedic devices market accounted for 47.2% of the global revenue, generating approximately USD 26.8 billion.

Statistic 57

The joint reconstruction segment dominated the orthopedic devices market with a 58% share in 2023, valued at USD 33.2 billion globally.

Statistic 58

Orthopedic devices market in Europe reached USD 15.4 billion in 2023, driven by aging population and advanced healthcare infrastructure.

Statistic 59

The Asia-Pacific orthopedic devices market grew by 6.8% in 2023, reaching USD 10.1 billion due to rising medical tourism.

Statistic 60

Global sales of hip implants totaled USD 8.7 billion in 2023, representing 15% of the overall orthopedic market.

Statistic 61

Knee replacement devices generated USD 12.4 billion worldwide in 2023, with a projected CAGR of 5.2% through 2028.

Statistic 62

The orthopedic trauma devices market was valued at USD 9.2 billion in 2023 globally.

Statistic 63

Spine orthopedic devices market hit USD 13.1 billion in 2023, fueled by increasing spinal disorders.

Statistic 64

Extremities orthopedic devices segment reached USD 6.5 billion in 2023, growing at 5.1% CAGR.

Statistic 65

Arthroscopy devices contributed USD 4.8 billion to the global market in 2023.

Statistic 66

Orthobiologics market size was USD 7.3 billion in 2023, with strong growth in regenerative medicine.

Statistic 67

U.S. hip and knee implant market was USD 11.5 billion in 2023.

Statistic 68

China orthopedic devices market expanded to USD 5.2 billion in 2023 at 8.4% growth.

Statistic 69

India’s orthopedic market valued at USD 1.2 billion in 2023, projected to double by 2030.

Statistic 70

Brazil orthopedic devices sales reached USD 1.8 billion in 2023.

Statistic 71

Japan’s market for orthopedic implants was USD 3.4 billion in 2023.

Statistic 72

German orthopedic devices market stood at USD 4.1 billion in 2023.

Statistic 73

UK orthopedic market generated USD 2.3 billion in 2023 revenues.

Statistic 74

Canadian orthopedic devices market was USD 1.9 billion in 2023.

Statistic 75

Australian market for orthopedics hit USD 1.1 billion in 2023.

Statistic 76

South Korea orthopedic devices valued at USD 1.4 billion in 2023.

Statistic 77

Orthopedic braces and supports market reached USD 5.6 billion globally in 2023.

Statistic 78

Bioabsorbable fixation devices market was USD 1.2 billion in 2023.

Statistic 79

Global orthopedic software market size was USD 2.1 billion in 2023.

Statistic 80

Patient-specific implants market valued at USD 3.8 billion in 2023.

Statistic 81

Robotic-assisted orthopedic surgery market was USD 1.5 billion in 2023.

Statistic 82

3D-printed orthopedic implants market reached USD 0.9 billion in 2023.

Statistic 83

Orthopedic prosthetics market size stood at USD 4.2 billion in 2023.

Statistic 84

Sports medicine devices market was USD 7.9 billion globally in 2023.

Statistic 85

Hip replacement segment held 52% of joint reconstruction market in 2023, valued at USD 17.2 billion globally.

Statistic 86

Knee implants accounted for 48% of joint replacement procedures worldwide in 2023, with over 1.2 million surgeries.

Statistic 87

Shoulder replacement devices represented 12% of upper extremity orthopedics, generating USD 2.1 billion in 2023.

Statistic 88

Ankle replacement market share was 3.5% of joint reconstruction, valued at USD 0.8 billion in 2023.

Statistic 89

Internal fixation devices for trauma held 45% of trauma segment, USD 4.1 billion in 2023.

Statistic 90

External fixators comprised 22% of orthopedic trauma devices, with USD 2.0 billion sales in 2023.

Statistic 91

Spinal fusion implants dominated spine segment at 55%, valued at USD 7.2 billion in 2023.

Statistic 92

Motion preservation devices in spine held 15% share, USD 2.0 billion in 2023.

Statistic 93

Extremity fixation systems accounted for 38% of extremities market, USD 2.5 billion in 2023.

Statistic 94

Arthroscopy shavers and burs represented 28% of arthroscopy tools, USD 1.3 billion in 2023.

Statistic 95

Orthobiologics like bone grafts held 42% of biologics segment, USD 3.1 billion in 2023.

Statistic 96

Bone cement products generated USD 1.1 billion, 15% of fixation accessories in 2023.

Statistic 97

Casting and splinting products market share was 25% of supportive devices, USD 1.4 billion in 2023.

Statistic 98

Orthopedic power tools held 35% of surgical instruments, valued at USD 1.8 billion in 2023.

Statistic 99

Patient matching implants for knees were 18% of knee segment in 2023.

Statistic 100

Ceramic hip implants comprised 22% of hip materials market in 2023.

Statistic 101

Metal-on-metal knee implants declined to 5% share due to safety concerns in 2023.

Statistic 102

Bioresorbable screws in trauma fixation reached 12% adoption, USD 0.5 billion in 2023.

Statistic 103

Interbody fusion cages held 60% of spinal fusion devices in 2023.

Statistic 104

Pedicle screws systems were 40% of spine instrumentation, USD 3.2 billion in 2023.

Statistic 105

Wrist implants for extremities were 15% of upper extremity market in 2023.

Statistic 106

Foot and ankle plating systems generated USD 0.9 billion, 28% of lower extremities in 2023.

Statistic 107

Fluid management systems in arthroscopy held 20% share, USD 1.0 billion in 2023.

Statistic 108

Platelet-rich plasma (PRP) orthobiologics accounted for 35% of biologics use in 2023.

Statistic 109

Bone void fillers represented 25% of orthobiologics, USD 1.8 billion in 2023.

Statistic 110

Knee braces for osteoarthritis held 40% of braces market in 2023.

Statistic 111

Drill bits and saw blades were 45% of power tools components in 2023.

Statistic 112

Hip prostheses with modular necks comprised 30% of primary hips in 2023.

Statistic 113

Unicondylar knee replacements were 10% of knee procedures in 2023.

Statistic 114

Compression plating systems dominated trauma at 55% in 2023.

Statistic 115

Dynamic hip screws held 18% of hip fracture fixation in 2023.

Statistic 116

Minimally invasive spine surgery implants grew to 25% share in 2023.

Statistic 117

Elbow replacement devices were 8% of upper extremities in 2023.

Statistic 118

Hand and wrist fixation plates USD 0.6 billion, 22% of hand segment in 2023.

Statistic 119

U.S. accounted for 46.8% of global orthopedic devices revenue in 2023.

Statistic 120

Europe held 25.3% market share in orthopedic devices, valued at USD 14.5 billion in 2023.

Statistic 121

Asia-Pacific region grew fastest at 6.5% CAGR, reaching USD 11.2 billion in 2023.

Statistic 122

Latin America orthopedic market was USD 3.4 billion in 2023, led by Brazil.

Statistic 123

Middle East and Africa segment valued at USD 2.1 billion in 2023, growing 5.8%.

Statistic 124

North America dominated joint reconstruction with 50% global share in 2023.

Statistic 125

Germany led Europe with USD 4.2 billion in orthopedic sales in 2023.

Statistic 126

China’s market expanded 9.1% to USD 5.8 billion in orthopedic devices 2023.

Statistic 127

India orthopedic devices imports reached USD 1.5 billion in 2023.

Statistic 128

Japan held 28% of Asia-Pacific market, USD 3.1 billion in 2023.

Statistic 129

U.K. orthopedic procedures grew 4.2% , market USD 2.5 billion in 2023.

Statistic 130

France’s spine devices market was USD 1.8 billion in 2023.

Statistic 131

Brazil generated USD 2.0 billion in orthopedics, 60% from imports in 2023.

Statistic 132

Australia’s market reached USD 1.3 billion, driven by sports injuries in 2023.

Statistic 133

South Korea exported USD 0.9 billion in orthopedic devices in 2023.

Statistic 134

Canada’s orthopedic market was USD 2.2 billion, 5% growth in 2023.

Statistic 135

Italy held 12% of European market, USD 1.7 billion in 2023.

Statistic 136

Mexico orthopedic devices valued at USD 1.1 billion in 2023.

Statistic 137

Saudi Arabia market grew 7.5% to USD 0.7 billion in 2023.

Statistic 138

Russia imported USD 0.8 billion in orthopedics despite sanctions in 2023.

Statistic 139

Turkey’s local production covered 45% of USD 0.9 billion market in 2023.

Statistic 140

South Africa orthopedic sales USD 0.4 billion, growing 6.2% in 2023.

Statistic 141

Singapore as hub imported USD 0.5 billion for re-export in 2023.

Statistic 142

Argentina market USD 0.6 billion, high inflation impact in 2023.

Statistic 143

UAE orthopedic tourism boosted market to USD 0.6 billion in 2023.

Statistic 144

Vietnam’s market doubled to USD 0.3 billion in past 5 years by 2023.

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
While a staggering $57.2 billion global industry quietly mends our bones and joints, this blog post will dissect the statistics driving the dynamic orthopedic device market from dominant joint reconstructions to emerging robotic surgeries.

Key Takeaways

  • The global orthopedic devices market was valued at USD 57.2 billion in 2023 and is expected to grow at a CAGR of 4.6% from 2024 to 2030, reaching USD 78.6 billion by 2030.
  • In 2022, the U.S. orthopedic devices market accounted for 47.2% of the global revenue, generating approximately USD 26.8 billion.
  • The joint reconstruction segment dominated the orthopedic devices market with a 58% share in 2023, valued at USD 33.2 billion globally.
  • Hip replacement segment held 52% of joint reconstruction market in 2023, valued at USD 17.2 billion globally.
  • Knee implants accounted for 48% of joint replacement procedures worldwide in 2023, with over 1.2 million surgeries.
  • Shoulder replacement devices represented 12% of upper extremity orthopedics, generating USD 2.1 billion in 2023.
  • Hospitals accounted for 62% of orthopedic device end-use market share in 2023, purchasing USD 35.5 billion worth.
  • Orthopedic clinics and ambulatory surgical centers held 28% share, valued at USD 16.0 billion in 2023.
  • Trauma centers represented 10% of end-users, with USD 5.7 billion in devices in 2023.
  • U.S. accounted for 46.8% of global orthopedic devices revenue in 2023.
  • Europe held 25.3% market share in orthopedic devices, valued at USD 14.5 billion in 2023.
  • Asia-Pacific region grew fastest at 6.5% CAGR, reaching USD 11.2 billion in 2023.
  • Stryker Corporation held 14.2% global market share in orthopedic devices in 2023, with revenues of USD 8.1 billion.
  • Zimmer Biomet captured 12.5% share, generating USD 7.4 billion from orthopedics in 2023.
  • DePuy Synthes (J&J) led with 15.8% share in hips and knees, USD 9.0 billion sales.

The global orthopedic device market is large and growing steadily across many segments and regions.

Competitive Landscape

  • Stryker Corporation held 14.2% global market share in orthopedic devices in 2023, with revenues of USD 8.1 billion.
  • Zimmer Biomet captured 12.5% share, generating USD 7.4 billion from orthopedics in 2023.
  • DePuy Synthes (J&J) led with 15.8% share in hips and knees, USD 9.0 billion sales.
  • Smith & Nephew had 9.3% market share, USD 5.3 billion orthopedic revenue in 2023.
  • Medtronic dominated spine with 18% share, USD 2.4 billion in 2023.
  • Globus Medical held 7.2% in spine devices, revenues USD 1.2 billion in 2023.
  • Wright Medical (Stryker) had 6.8% in extremities post-acquisition in 2023.
  • Conformis specialized in patient-specific knees, 1.5% niche share in 2023.
  • NuVasive (Globus) 5.4% spine share, USD 1.1 billion before merger in 2023.
  • Paragon 28 led foot/ankle with 4.1% share, USD 0.6 billion in 2023.
  • Integra LifeSciences held 3.7% in orthobiologics, USD 1.0 billion revenue.
  • Arthrex dominated arthroscopy at 22%, USD 3.2 billion in sports medicine 2023.
  • CONMED 4.5% in arthroscopy tools, USD 0.7 billion in 2023.
  • Becton Dickinson (BD) 5.2% in trauma fixation post-acquisition.
  • Exactech had 2.8% in joints before bankruptcy filing in 2023.
  • SeaSpine (N脊椎) 2.1% share in biologics and spine in 2023.
  • Orthofix Medical 3.0% in spine and trauma, USD 0.5 billion.
  • Coloplast entered with 1.2% via acquisitions in pelvic orthopedics 2023.
  • BioVentrix niche in cardiac ortho crossover, 0.5% emerging share.
  • TeDan Surgical Innovations 0.8% in power tools.
  • In2Bones Global 1.1% in upper extremities trauma.
  • Core Medical 0.9% in braces and supports.
  • DJO Global (Colfax) 4.2% in rehab devices pre-sale.
  • Enovis post-merger held 6.5% in extremities and rehab 2023.
  • Hologic 2.3% via interstitial brachytherapy ortho apps.
  • Implanet niche dynamic stabilization 0.4% spine share.
  • Joimax 1.8% in endoscopic spine.
  • K2M (Globus) integrated 3.5% complex spine share.
  • Lanx (ZT) legacy 1.0% in fusion tech.
  • Misonix (Stryker) ultrasonic ortho tools 0.7% share.

Competitive Landscape Interpretation

The orthopedic market is a well-organized, trillion-dollar brawl where giants like J&J and Stryker elbow for broad dominance, while clever niche players like Arthrex and Paragon 28 prove there's still serious money in owning a specific corner of the human skeleton.

End-User Segments

  • Hospitals accounted for 62% of orthopedic device end-use market share in 2023, purchasing USD 35.5 billion worth.
  • Orthopedic clinics and ambulatory surgical centers held 28% share, valued at USD 16.0 billion in 2023.
  • Trauma centers represented 10% of end-users, with USD 5.7 billion in devices in 2023.
  • U.S. hospitals performed 70% of joint replacements, using 55% of implants in 2023.
  • European ambulatory centers grew 7.2% in orthopedic procedures, handling 22% market in 2023.
  • Asia-Pacific specialty clinics adopted 35% more orthobiologics in 2023.
  • Home healthcare for braces and supports reached 12% end-use share in 2023, USD 6.7 billion.
  • Rehabilitation centers used 18% of extremity devices in 2023 globally.
  • Sports injury clinics accounted for 15% of arthroscopy device purchases in 2023.
  • Academic medical centers conducted 25% of spine surgeries in U.S. in 2023.
  • Private orthopedic practices in India handled 40% of trauma cases in 2023.
  • Veterans hospitals in U.S. procured USD 1.2 billion in orthopedics in 2023.
  • Pediatric hospitals used 8% of pediatric-specific orthopedic devices in 2023.
  • Dialysis centers integrated orthopedics for 5% of bone health devices in 2023.
  • Outpatient facilities in Europe rose to 32% of knee replacements in 2023.
  • Military medical facilities purchased USD 0.8 billion in trauma devices in 2023.
  • Physiotherapy centers adopted 20% of supportive braces market in 2023.
  • Emergency departments handled 45% of initial trauma device applications in 2023.
  • Cosmetic surgery clinics used 7% of facial orthopedics in 2023.
  • Geriatric care homes increased orthopedic aid usage by 15% in 2023.
  • Dental clinics for TMJ orthopedics accounted for 3% niche in 2023.
  • Occupational health centers procured 10% of work-related injury devices in 2023.
  • Bariatric surgery follow-ups used 6% of joint support devices post-weight loss in 2023.
  • Oncology centers integrated 4% orthopedic prosthetics for bone cancer in 2023.

End-User Segments Interpretation

While hospitals remain the heavyweight champions of orthopedic spending, the real story of 2023 is a global shift toward outpatient and specialized settings, proving that the future of bone and joint care is increasingly walking out the door.

Market Size and Growth

  • The global orthopedic devices market was valued at USD 57.2 billion in 2023 and is expected to grow at a CAGR of 4.6% from 2024 to 2030, reaching USD 78.6 billion by 2030.
  • In 2022, the U.S. orthopedic devices market accounted for 47.2% of the global revenue, generating approximately USD 26.8 billion.
  • The joint reconstruction segment dominated the orthopedic devices market with a 58% share in 2023, valued at USD 33.2 billion globally.
  • Orthopedic devices market in Europe reached USD 15.4 billion in 2023, driven by aging population and advanced healthcare infrastructure.
  • The Asia-Pacific orthopedic devices market grew by 6.8% in 2023, reaching USD 10.1 billion due to rising medical tourism.
  • Global sales of hip implants totaled USD 8.7 billion in 2023, representing 15% of the overall orthopedic market.
  • Knee replacement devices generated USD 12.4 billion worldwide in 2023, with a projected CAGR of 5.2% through 2028.
  • The orthopedic trauma devices market was valued at USD 9.2 billion in 2023 globally.
  • Spine orthopedic devices market hit USD 13.1 billion in 2023, fueled by increasing spinal disorders.
  • Extremities orthopedic devices segment reached USD 6.5 billion in 2023, growing at 5.1% CAGR.
  • Arthroscopy devices contributed USD 4.8 billion to the global market in 2023.
  • Orthobiologics market size was USD 7.3 billion in 2023, with strong growth in regenerative medicine.
  • U.S. hip and knee implant market was USD 11.5 billion in 2023.
  • China orthopedic devices market expanded to USD 5.2 billion in 2023 at 8.4% growth.
  • India’s orthopedic market valued at USD 1.2 billion in 2023, projected to double by 2030.
  • Brazil orthopedic devices sales reached USD 1.8 billion in 2023.
  • Japan’s market for orthopedic implants was USD 3.4 billion in 2023.
  • German orthopedic devices market stood at USD 4.1 billion in 2023.
  • UK orthopedic market generated USD 2.3 billion in 2023 revenues.
  • Canadian orthopedic devices market was USD 1.9 billion in 2023.
  • Australian market for orthopedics hit USD 1.1 billion in 2023.
  • South Korea orthopedic devices valued at USD 1.4 billion in 2023.
  • Orthopedic braces and supports market reached USD 5.6 billion globally in 2023.
  • Bioabsorbable fixation devices market was USD 1.2 billion in 2023.
  • Global orthopedic software market size was USD 2.1 billion in 2023.
  • Patient-specific implants market valued at USD 3.8 billion in 2023.
  • Robotic-assisted orthopedic surgery market was USD 1.5 billion in 2023.
  • 3D-printed orthopedic implants market reached USD 0.9 billion in 2023.
  • Orthopedic prosthetics market size stood at USD 4.2 billion in 2023.
  • Sports medicine devices market was USD 7.9 billion globally in 2023.

Market Size and Growth Interpretation

It seems humanity's collective skeleton is going premium, with the global market for its refurbishment set to reach nearly $80 billion by 2030, proving that while our bodies are on a payment plan, the orthopedic industry is cashing in.

Product Segments

  • Hip replacement segment held 52% of joint reconstruction market in 2023, valued at USD 17.2 billion globally.
  • Knee implants accounted for 48% of joint replacement procedures worldwide in 2023, with over 1.2 million surgeries.
  • Shoulder replacement devices represented 12% of upper extremity orthopedics, generating USD 2.1 billion in 2023.
  • Ankle replacement market share was 3.5% of joint reconstruction, valued at USD 0.8 billion in 2023.
  • Internal fixation devices for trauma held 45% of trauma segment, USD 4.1 billion in 2023.
  • External fixators comprised 22% of orthopedic trauma devices, with USD 2.0 billion sales in 2023.
  • Spinal fusion implants dominated spine segment at 55%, valued at USD 7.2 billion in 2023.
  • Motion preservation devices in spine held 15% share, USD 2.0 billion in 2023.
  • Extremity fixation systems accounted for 38% of extremities market, USD 2.5 billion in 2023.
  • Arthroscopy shavers and burs represented 28% of arthroscopy tools, USD 1.3 billion in 2023.
  • Orthobiologics like bone grafts held 42% of biologics segment, USD 3.1 billion in 2023.
  • Bone cement products generated USD 1.1 billion, 15% of fixation accessories in 2023.
  • Casting and splinting products market share was 25% of supportive devices, USD 1.4 billion in 2023.
  • Orthopedic power tools held 35% of surgical instruments, valued at USD 1.8 billion in 2023.
  • Patient matching implants for knees were 18% of knee segment in 2023.
  • Ceramic hip implants comprised 22% of hip materials market in 2023.
  • Metal-on-metal knee implants declined to 5% share due to safety concerns in 2023.
  • Bioresorbable screws in trauma fixation reached 12% adoption, USD 0.5 billion in 2023.
  • Interbody fusion cages held 60% of spinal fusion devices in 2023.
  • Pedicle screws systems were 40% of spine instrumentation, USD 3.2 billion in 2023.
  • Wrist implants for extremities were 15% of upper extremity market in 2023.
  • Foot and ankle plating systems generated USD 0.9 billion, 28% of lower extremities in 2023.
  • Fluid management systems in arthroscopy held 20% share, USD 1.0 billion in 2023.
  • Platelet-rich plasma (PRP) orthobiologics accounted for 35% of biologics use in 2023.
  • Bone void fillers represented 25% of orthobiologics, USD 1.8 billion in 2023.
  • Knee braces for osteoarthritis held 40% of braces market in 2023.
  • Drill bits and saw blades were 45% of power tools components in 2023.
  • Hip prostheses with modular necks comprised 30% of primary hips in 2023.
  • Unicondylar knee replacements were 10% of knee procedures in 2023.
  • Compression plating systems dominated trauma at 55% in 2023.
  • Dynamic hip screws held 18% of hip fracture fixation in 2023.
  • Minimally invasive spine surgery implants grew to 25% share in 2023.
  • Elbow replacement devices were 8% of upper extremities in 2023.
  • Hand and wrist fixation plates USD 0.6 billion, 22% of hand segment in 2023.

Product Segments Interpretation

While hips are the moneymakers and knees are the workhorses of the orthopedic world, the entire industry builds its fortune, one precise and sometimes discounted screw, plate, and replacement joint at a time, on our collective human talent for falling apart.

Regional Insights

  • U.S. accounted for 46.8% of global orthopedic devices revenue in 2023.
  • Europe held 25.3% market share in orthopedic devices, valued at USD 14.5 billion in 2023.
  • Asia-Pacific region grew fastest at 6.5% CAGR, reaching USD 11.2 billion in 2023.
  • Latin America orthopedic market was USD 3.4 billion in 2023, led by Brazil.
  • Middle East and Africa segment valued at USD 2.1 billion in 2023, growing 5.8%.
  • North America dominated joint reconstruction with 50% global share in 2023.
  • Germany led Europe with USD 4.2 billion in orthopedic sales in 2023.
  • China’s market expanded 9.1% to USD 5.8 billion in orthopedic devices 2023.
  • India orthopedic devices imports reached USD 1.5 billion in 2023.
  • Japan held 28% of Asia-Pacific market, USD 3.1 billion in 2023.
  • U.K. orthopedic procedures grew 4.2% , market USD 2.5 billion in 2023.
  • France’s spine devices market was USD 1.8 billion in 2023.
  • Brazil generated USD 2.0 billion in orthopedics, 60% from imports in 2023.
  • Australia’s market reached USD 1.3 billion, driven by sports injuries in 2023.
  • South Korea exported USD 0.9 billion in orthopedic devices in 2023.
  • Canada’s orthopedic market was USD 2.2 billion, 5% growth in 2023.
  • Italy held 12% of European market, USD 1.7 billion in 2023.
  • Mexico orthopedic devices valued at USD 1.1 billion in 2023.
  • Saudi Arabia market grew 7.5% to USD 0.7 billion in 2023.
  • Russia imported USD 0.8 billion in orthopedics despite sanctions in 2023.
  • Turkey’s local production covered 45% of USD 0.9 billion market in 2023.
  • South Africa orthopedic sales USD 0.4 billion, growing 6.2% in 2023.
  • Singapore as hub imported USD 0.5 billion for re-export in 2023.
  • Argentina market USD 0.6 billion, high inflation impact in 2023.
  • UAE orthopedic tourism boosted market to USD 0.6 billion in 2023.
  • Vietnam’s market doubled to USD 0.3 billion in past 5 years by 2023.

Regional Insights Interpretation

While the U.S. still rules the orthopedic throne, the world is quite literally getting its bones fixed everywhere else, from Germany's engineering to China's surging market and Brazil's import-heavy demand, proving that when it comes to mending humanity, it's a truly global, and often locally complex, affair.

Sources & References